Table 3 Normative evaluation of reporting in the health economic assessment of SBRT in the treatment of HCC (CHEERS scale)
Entry | Hayeon Kim [17] | Leung [18] | Pollom [9] | Leung [20] | Parikh [21] |
|---|---|---|---|---|---|
Title and abstract | |||||
1. Title | Y | Y | Y | Y | Y |
2. Abstract | Y | Y | Y | P | Y |
Introduction | |||||
3. Background and objective | Y | Y | Y | Y | Y |
Methods | |||||
4. Target population and subgroups | P | P | Y | P | Y |
5. Setting and location | Y | Y | Y | Y | Y |
6. Study perspective | Y | Y | Y | Y | Y |
7. Comparators | Y | Y | Y | Y | Y |
8. Time horizon | Y | Y | Y | Y | Y |
9. Discount rate | P | P | P | P | – |
10. Indicators of health outcomes | Y | Y | Y | Y | Y |
11. Measurement of effectiveness | |||||
11a Effectiveness estimates1 | – | – | – | – | Y |
11b Effectiveness estimates1 | P | Y | P | Y | – |
12. Measurement and valuation of preference-based outcomes | Y | Y | Y | Y | Y |
13. Estimating resources and costs | |||||
13a. Estimating resources and costs | – | – | – | – | Y |
13b. Estimating resources and costs | Y | Y | Y | Y | – |
14. Currency, price date, and conversion | Y | Y | Y | Y | – |
15. Choice of model | Y | Y | Y | Y | – |
16. Model assumptions | Y | Y | Y | Y | – |
17. Analytical methods | Y | Y | Y | Y | Y |
Results | |||||
18. Study parameters | Y | Y | Y | Y | Y |
19. Incremental costs and outcomes | Y | Y | Y | Y | Y |
Characterizing uncertainty | |||||
20a. Characterizing uncertainty | – | – | – | – | Y |
20b. Characterizing uncertainty | Y | Y | Y | Y | – |
21. Characterizing heterogeneity | – | – | – | – | – |
Discussion | |||||
22. The consistency of major findings, limitations and generalizability of the article with current knowledge | Y | Y | Y | Y | Y |
Other | |||||
23. Source of funding | N | Y | Y | N | N |
24. Conflicts of interest | Y | Y | Y | Y | Y |
Actual scorea | 20.5 | 22 | 22 | 20.5 | 18 |
Adjusted total scoreb | 23 | 23 | 23 | 23 | 20 |
Adjusted score (%)c | 89 | 96 | 96 | 89 | 90 |